Trials / Conditions / Sodium-glucose Co-transporter 2 Inhibitors
Sodium-glucose Co-transporter 2 Inhibitors
6 registered clinical trials studyying Sodium-glucose Co-transporter 2 Inhibitors — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic K NCT07405216 | Centenario Hospital Miguel Hidalgo | Phase 4 |
| Completed | Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diab NCT07302464 | Ain Shams University | — |
| Recruiting | meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis NCT05715814 | University Health Network, Toronto | Phase 3 |
| Recruiting | Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients NCT06398977 | Sichuan Academy of Medical Sciences | N/A |
| Unknown | Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. NCT04780438 | G.Gennimatas General Hospital | EARLY_Phase 1 |
| Unknown | Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percuta NCT04806633 | G.Gennimatas General Hospital | EARLY_Phase 1 |